A 2026 scientific review examined how phytocannabinoids affect bone health, with CBD receiving the most research attention. Bones are constantly being renewed through a balance between osteoclasts, which break down old bone, and osteoblasts, which build new bone. Laboratory studies reviewed in the article found that CBD may reduce osteoclast activity while promoting osteoblast activity. […]
Category: Cannabinoid
CBD Shows Potential for Reducing Alcohol Use and Alcohol-Related Harm (Pub. Sept. 2026)
A 2026 review examined whether cannabidiol (CBD) could have a therapeutic role in alcohol use disorder (AUD). Animal studies have produced some of the strongest evidence so far, with several showing that CBD reduced alcohol consumption, alcohol-seeking behavior, and relapse-like behavior. Researchers also found preclinical evidence that CBD may lessen some symptoms of alcohol withdrawal […]
Cannabinoids, the Microbiome, and Melanoma Treatment (pub. Aug 2026)
A 2026 scientific review explored the relationship between the endocannabinoid system, cannabinoids, the gut and skin microbiome, and melanoma. Researchers noted that although targeted therapies and immunotherapies have improved melanoma treatment, treatment resistance and adverse effects remain significant challenges. Preclinical research suggests that cannabinoids may influence cancer cells and immune activity, prompting interest in compounds […]